|
ASF1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.83064674530442E-12 |
| Normal-vs-Stage2 |
1.235870E-02 |
| Normal-vs-Stage3 |
1.67679999996118E-06 |
| Normal-vs-Stage4 |
4.224800E-03 |
| Stage1-vs-Stage2 |
5.767600E-01 |
| Stage1-vs-Stage3 |
6.634600E-04 |
| Stage1-vs-Stage4 |
4.322000E-02 |
| Stage2-vs-Stage3 |
1.885730E-02 |
| Stage2-vs-Stage4 |
8.627500E-02 |
| Stage3-vs-Stage4 |
7.538000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.59699999890961E-08 |
| Normal-vs-Asian |
1.968480E-02 |
| Caucasian-vs-AfricanAmerican |
6.410200E-01 |
| Caucasian-vs-Asian |
2.960400E-01 |
| AfricanAmerican-vs-Asian |
1.679970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
5.76609981983722E-10 |
| Male-vs-Female |
1.055560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.23689999967469E-07 |
| Normal-vs-Extreme_Weight |
9.64329727182189E-11 |
| Normal-vs-Obese |
6.91620000159432E-08 |
| Normal-vs-Extreme_Obese |
6.08069999907812E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.345410E-01 |
| Normal_Weight-vs-Obese |
5.980400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.830000E-04 |
| Extreme_Weight-vs-Obese |
5.922400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.280400E-03 |
| Obese-vs-Extreme_Obese |
1.789720E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.026600E-04 |
| Normal-vs-Age(41-60Yrs) |
7.7715611723761E-15 |
| Normal-vs-Age(61-80Yrs) |
2.81696888038141E-12 |
| Normal-vs-Age(81-100Yrs) |
1.008390E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.940100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.134220E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.217760E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.341030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.155800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.522400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
7.26769755488021E-11 |
| Normal-VS-KIRP CIMP |
3.440800E-04 |
| Normal-VS-Unclassified PRCC |
8.57209999982622E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.561620E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.119200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.073030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.361300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.739800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.923790E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.51680000027544E-07 |
| Normal-vs-N1 |
1.82289999994811E-06 |
| Normal-vs-N2 |
1.022570E-01 |
| N0-vs-N1 |
1.523820E-03 |
| N0-vs-N2 |
4.888100E-02 |
| N1-vs-N2 |
8.445200E-01 |
|
|
